FEV1, or forced expiratory volume in one second, is the amount of air you can forcefully blow out in the first second of a hard exhale. It is measured during a breathing test called spirometry. Doctors use it to gauge how well the lungs move air and whether airflow is obstructed or restricted.
Origin
The measurement grew out of spirometry, a technique pioneered by John Hutchinson in the 1840s. Standardized FEV1 testing became routine in twentieth-century pulmonary medicine and occupational health screening.
Significance in Asbestos Context
For someone with asbestos disease, FEV1 is part of the pulmonary function testing that documents how much lung capacity has been lost. Asbestosis and pleural disease typically cause a restrictive pattern, where both FEV1 and total lung volume fall together, rather than the obstructive pattern seen in smoking-related COPD. These numbers appear in medical records and can support both diagnosis and the measure of impairment in a claim. Because the test depends on effort, results are usually repeated. If you smoked, doctors look at the overall pattern to separate asbestos-related restriction from smoking-related obstruction.
Example Sentence
His FEV1 had dropped to 62 percent of predicted, consistent with the restrictive impairment expected in asbestosis.
Related Terms
Spirometry, Pulmonary Function Test, FVC, Restrictive Lung Disease, Diffusing Capacity
Notes
- Ask for your full pulmonary function report, not just the FEV1; the FEV1/FVC ratio distinguishes restriction from obstruction.
- Keep copies of serial tests, since a declining trend documents progression and impairment.
- Give full effort and follow the technician's coaching, because low effort can understate or distort results.
In the research library
111 studies in our medical research library mention FEV1 in the title or abstract. Among the most cited:
- Effectiveness of postal smoking cessation advice: a randomized controlled trial in young men with reduced FEV1 and asbestos exposureS. Humerfelt, G.E. Eide, G. Kvåle, et al, 1998 · The European Respiratory Journal · cited 47 times
- Spirometry, rapid FEV1 decline, and lung cancer among asbestos exposed heavy smokersJ.W. Chien, D.H. Au, M.J. Barnett, et al, 2007 · COPD · cited 10 times
- Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agentsP.S. Bakke, V. Baste, R. Hanoa, et al, 1991 · Thorax · cited 189 times
- High resolution computed tomography and lung function in asbestos-exposed workers with normal chest radiographsC.A. Staples, G. Gamsu, C.S. Ray, et al, 1989 · The American Review of Respiratory Disease · cited 122 times
- The relation among pulmonary function, chest roentgenographic abnormalities, and smoking status in an asbestos-exposed cohortL. Rosenstock, S. Barnhart, N.J. Heyer, et al, 1988 · The American Review of Respiratory Disease · cited 94 times
The journals that publish most on it: American Journal of Industrial Medicine (17), British Journal of Industrial Medicine (9), The American Review of Respiratory Disease (9).
Category: Diagnostic Tools & Biomarkers · All Lexicon terms A–Z
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.